Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
Matthew Smeds, Professor of Vascular Surgery at Saint Louis University Vascular Surgery, shared a post on X:
”How should we manage thoracic endograft thrombosis when it occurs?
There’s little evidence and strategies range from anticoagulation to relining, bypass, or explantation.
In this case, recurrent thrombus plus mesenteric embolization was treated with redo TEVAR plus SMA thrombectomy.”
JVS-Cases Innovations and Techniques shared a post on X about a recent article by Yaima C. Valdes et al, published in Journal of Vascular Surgery: Cases and Innovative Techniques, adding:
”5 years after TEVAR, the thrombus came back.
This case of late thoracic endograft thrombosis with mesenteric embolization, without endoleak, migration, or identified hypercoagulability, raises questions about long-term surveillance.”
Title: Recurrent thoracic aortic stent graft thrombosis
Authors: Yaima C. Valdes, Faisal Khan, Thomas Abbruzzese
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 13:42Manideepa Maji: IV Iron Safety in Heart Failure
-
Nov 11, 2026, 13:36Wilson Andrés Vásconez Samaniego: NGS-Based Genomic Profiling Before Gene Therapy for Hemoglobinopathies
-
Nov 11, 2026, 13:34Mathieu Jackson: WFH Opens Registration for 2027 Comprehensive Care Summit
-
Nov 11, 2026, 13:29Maia Meier: Recognising Bleeding Disorders Through the 7-2-1 Rule
-
Nov 11, 2026, 13:17Kiran Rajeev T: Elsevier Releases New Practical Handbook on Transfusion Medicine
-
Nov 11, 2026, 13:01Reza Shojaei: FDA Approval Marks Milestone for Factor XIa-Targeted Therapy
-
Nov 11, 2026, 11:35Paulus Kirchhof: Oral Anticoagulation in Atrial Fibrillation After Intracranial Hemorrhage
-
Nov 11, 2026, 11:28Arturo Cesaro: Lp(a) Lowered by 78% but Cardiovascular Outcomes Remain Unchanged
-
Nov 11, 2026, 09:40Diego Martin Rabasedas: Celebrating National Voluntary Blood Donor Day in Argentina